×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: fda | drug | avacopan

US FDA Approves ChemoCentryx Drug to Treat Rare Autoimmune Disease

The U.S. Food and Drug Administration building behind an FDA logo
(AP Photo/Jacquelyn Martin, File)

Friday, 08 October 2021 07:17 AM EDT

The U.S. Food and Drug Administration on Friday approved ChemoCentryx Inc's lead drug candidate, Avacopan, for treating a rare, fatal autoimmune disease, the biopharmaceutical company said.

© 2022 Thomson/Reuters. All rights reserved.


FDA-Approved-Drugs
The U.S. Food and Drug Administration on Friday approved ChemoCentryx Inc's lead drug candidate, Avacopan, for treating a rare, fatal autoimmune disease.
fda, drug, avacopan
26
2021-17-08
Friday, 08 October 2021 07:17 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved